NCT01689714View on ClinicalTrials.gov

Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

August 31, 2005

Conditions
Ovarian CarcinomaRecurrent Endometrial Carcinoma
Interventions
DRUG

Tc 99m EC20

Sponsors

Lead Sponsor

Endocyte
All Listed Sponsors
lead

Endocyte

INDUSTRY

NCT01689714 - Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma | Biotech Hunter | Biotech Hunter